Patients with sarcoma, especially those with high-risk factors, had a higher likelihood of developing complications from COVID-19, noted a registry-based retrospective study.

About 49% of the patients included in the study were hospitalized with COVID-19, and 9% died within 30 days of diagnosis, reported Michael Wagner of the University of Washington and Seattle Cancer Care Alliance, at the virtual Connective Tissue Oncology Society annual meeting. One-third of these patients were given supplemental oxygen, 12% were admitted to the ICU, and 6% needed mechanical ventilation. Additional follow-up revealed that 16% had died due to any cause.

The factors that were most associated with poor outcomes included Eastern Cooperative Oncology Group (ECOG) performance status (≥2 vs. 0) with an adjusted odds ratio (aOR) of 17.28, metastatic cancer to the lung vs. no metastatic cancer with aOR 7.65, other metastatic cancer vs. no metastatic cancer with aOR 4.28, pre-existing renal disease with aOR 3.33, and male sex with an OR of 2.13… (Medpage Today)